Panacea Biotec Limited
Panacea Biotec Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: PANACEABIO and BSE: 531349 (ISIN INE922B01023).
It has a market capitalisation of ₹2,140 crore, a last close of ₹349.05 on 2026-10-19, a one-year return of -21.8%.
Valuation: a price-to-book ratio of 2.56x, a dividend yield of 0.0%.
Profitability: return on equity of -0.6%, return on capital employed of -0.1%, an operating margin of 0.3%.
Growth: sales growth of 11.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.03x, promoter holding of 72.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 2,140 |
| Last close | ₹349.05 |
| P/B | 2.56x |
| Dividend yield | 0.0% |
| ROE (FY) | -0.6% |
| ROCE (FY) | -0.1% |
| Operating margin (TTM) | 0.3% |
| Sales growth, 3-year CAGR | 11.6% |
| Debt / equity | 0.03x |
| Promoter holding | 72.5% |
| 1-year return | -21.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means